Isolation of mesenchymal stem-like cells in meningioma specimens

International Journal of Oncology

Volumn 43, Issue 4, 2013, Pages 1260-1268

  Lim, Hyo Yeol ^a   Kim, Kyung Min ^b   Kim, Bo Kyung ^a   Shim, Jin Kyoung ^a   Lee, Ji Hyun ^a   Huh, Yong Min ^c   Kim, Se Hoon ^a   Kim, Eui Hyun ^a   Park, Eun Kyung ^a   Shim, Kyu Won ^a   Chang, Jong Hee ^a   Kim, Dong Seok ^a   Kim, Sun Ho ^a   Hong, Yong Kil ^d   Lee, Su Jae ^e   Kang, Seok Gu ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Medical Science ^*  (United States)

^c Radiology   (United States)

^d The Catholic University of Korea   (South Korea)

^e Hanyang University   (South Korea)

Author keywords

Meningioma; Meningioma stroma; Mesenchymal stem like cells; Microenvironment; Perivascular area

Indexed keywords

CD45 ANTIGEN; ENDOGLIN;

ADHERENT CELL; ADIPOCYTE; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOCYTE; PERICYTE; PRIORITY JOURNAL; SPINDLE CELL; SURVIVAL RATE; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ADIPOGENESIS; ANIMALS; ANTIGENS, CD; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; CHONDROGENESIS; FLOW CYTOMETRY; HUMANS; MENINGIOMA; MESENCHYMAL STROMAL CELLS; MICE; OSTEOGENESIS; RECEPTORS, CELL SURFACE;

EID: 84882395234     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2053     Document Type: Article

References (50)

1. Fomchenko EI and Holland EC: Stem cells and brain cancer. Exp Cell Res 306: 323-329, 2005.
2. Galderisi U, Cipollaro M and Giordano A: Stem cells and brain cancer. Cell Death Differ 13: 5-11, 2006.
3. Kong BH, Park NR, Shim JK, et al: Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens. Childs Nerv Syst 29: 217-229, 2013.
4. Liotta LA and Kohn EC: The microenvironment of the tumour-host interface. Nature 411: 375-379, 2001.
5. Xouri G and Christian S: Origin and function of tumor stroma fibroblasts. Semin Cell Dev Biol 21: 40-46, 2010.
6. Shin GY, Shim JK, Lee JH, et al: Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation. Childs Nerv Syst 29: 55-64, 2013.
7. Kong BH, Shin HD, Kim SH, et al: Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma. Int J Oncol 42: 1754-1762, 2013.
8. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 133: 571-573, 1889.
9. Fidler IJ and Poste G: The 'seed and soil' hypothesis revisited. Lancet Oncol 9: 808, 2008.
10. Mendoza M and Khanna C: Revisiting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 41: 1452-1462, 2009.
11. Kim SM, Kang SG, Park NR, et al: Presence of glioma stroma mesenchymal stem cells in a murine orthotopic glioma model. Childs Nerv Syst 27: 911-922, 2011.
12. Kim YG, Jeon S, Sin GY, et al: Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens. Childs Nerv Syst 29: 549-563, 2013.
13. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
14. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004.
15. Hoelzinger DB, Demuth T and Berens ME: Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99: 1583-1593, 2007.
16. Oliver L, Olivier C, Marhuenda FB, Campone M and Vallette FM: Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr Mol Pharmacol 2: 263-284, 2009.
17. Kanamori M, Kawaguchi T, Berger MS and Pieper RO: Intracranial microenvironment reveals independent opposing functions of host alphaVbeta3 expression on glioma growth and angiogenesis. J Biol Chem 281: 37256-37264, 2006.
18. Stewart PA, Farrell CL and Del Maestro RF: The effect of cellular microenvironment on vessels in the brain. Part 1: vessel structure in tumour, peritumour and brain from humans with malignant glioma. Int J Radiat Biol 60: 125-130, 1991.
19. Kang SG, Shinojima N, Hossain A, et al: Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery 67: 711-720, 2010.
20. Lee CH, Jung KW, Yoo H, Park S and Lee SH: Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc 48: 145-152, 2010.
21. Hueng DY, Sytwu HK, Huang SM, Chang C and Ma HI: Isolation and characterization of tumor stem-like cells from human meningiomas. J Neurooncol 104: 45-53, 2011.
22. Rath P, Miller DC, Litofsky NS, et al: Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma. Exp Mol Pathol 90: 179-188, 2011.
23. Hu D, Wang X, Mao Y and Zhou L: Identification of CD105 (endoglin)-positive stem-like cells in rhabdoid meningioma. J Neurooncol 106: 505-517, 2012.
24. Mosnier JF, Perret AG, Scoazec JY and Brunon J: Expression of beta2 integrins and macrophage-associated antigens in meningeal tumours. Virchows Arch 436: 131-137, 2000.
25. Kimura Y, Matsumae M and Tsutsumi Y: Pericellular deposition of basement membrane material in myxoid meningioma: immunohistochemical evidence for unbalanced production of type IV collagen and laminin. Pathol Int 48: 53-57, 1998.
26. Shamah SM, Alberta JA, Giannobile WV, et al: Detection of activated platelet-derived growth factor receptors in human meningioma. Cancer Res 57: 4141-4147, 1997.
27. Nystrom SH: Fine structure of tumour stroma and blood vessel stroma in human supratentorial menigioma. Nature 194: 587-588, 1962.
28. Majumdar K, Mandal S, Thakkar R, Saran RK and Srivastava AK: Meningeal osteochondroma simulating meningioma with metaplastic change: a rare golf-ball-like lesion of non-meningothelial mesenchymal origin. Brain Tumor Pathol: Mar 2, 2013 (Epub ahead of print).
29. Celebre A, Wu MY, Danielson B, et al: Anaplastic meningioma with extensive single-cell infiltration: a potential role for epithelial-mesenchymal transformation in the progression of a meningothelial tumour? Histopathology 62: 1111-1114, 2013.
30. Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007.
31. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E and Fagioli F: Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 86: 1099-1100, 2001.
32. Lennon DP and Caplan AI: Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol 34: 1604-1605, 2006.
33. Dominici M, Le Blanc K, Mueller I, et al: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317, 2006.
34. Lal S, Lacroix M, Tofilon P, Fuller GN, Sawaya R and Lang FF: An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg 92: 326-333, 2000.
35. Nakamizo A, Marini F, Amano T, et al: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318, 2005.
36. da Silva Meirelles L, Chagastelles PC and Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-2213, 2006.
37. El-Haibi CP and Karnoub AE: Mesenchymal stem cells in the pathogenesis and therapy of breast cancer. J Mammary Gland Biol Neoplasia 15: 399-409, 2010.
38. Karnoub AE, Dash AB, Vo AP, et al: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563, 2007.
39. Hall B, Andreeff M and Marini F: The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 180: 263-283, 2007.
40. Feigin I: Mixed mesenchymal tumors: meningioma and nerve sheath tumor. J Neuropathol Exp Neurol 37: 459-470, 1978.
41. Ng HK, Tse CC and Lo ST: Meningiomas and arachnoid cells: an immunohistochemical study of epithelial markers. Pathology 19: 253-257, 1987.
42. Kamitani H, Masuzawa H, Kanazawa I and Kubo T: Recurrence of convexity meningiomas: tumor cells in the arachnoid membrane. Surg Neurol 56: 228-235, 2001.
43. Lopes CA and Mair WG: Tubular structures in arachnoid cells. Acta Neuropathol 27: 363-368, 1974.
44. Ohnishi Y, Iwatsuki K, Morii E, et al: Histopathological study of spinal meningioma originating from the arachnoid villi. Brain Tumor Pathol 28: 77-81, 2011.
45. Cheifetz S, Bellon T, Cales C, et al: Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267: 19027-19030, 1992.
46. Behrem S, Zarkovic K, Eskinja N and Jonjic N: Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. Croat Med J 46: 417-422, 2005.
47. Barresi V and Barresi G: Endoglin: a marker of neoplasias or rather of neo-angiogenesis? Head Neck 32: 970-971, 2010.
48. Yen BL, Huang HI, Chien CC, et al: Isolation of multipotent cells from human term placenta. Stem Cells 23: 3-9, 2005.
49. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L and Peault B: Perivascular multipotent progenitor cells in human organs. Ann NY Acad Sci 1176: 118-123, 2009.
50. Galie M, Konstantinidou G, Peroni D, et al: Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene 27: 2542-2551, 2008.